ArticlePDF Available

Abstract and Figures

The belief that Homo sapiens is absolutely dimorphic with the respect to sex chromosome composition, gonadal structure, hormone levels, and the structure of the internal genital duct systems and external genitalia, derives from the platonic ideal that for each sex there is a single, universally correct developmental pathway and outcome. We surveyed the medical literature from 1955 to the present for studies of the frequency of deviation from the ideal male or female. We conclude that this frequency may be as high as 2% of live births. The frequency of individuals receiving "corrective" genital surgery, however, probably runs between 1 and 2 per 1,000 live births (0.1-0.2%). Am. J. Hum. Biol. 12:151-166, 2000. Copyright 2000 Wiley-Liss, Inc.
Content may be subject to copyright.
How Sexually Dimorphic Are We? Review and Synthesis
Department of Molecular and Cell Biology and Biochemistry, Brown
University, Providence, Rhode Island
ABSTRACT The belief that Homo sapiens is absolutely dimorphic with
the respect to sex chromosome composition, gonadal structure, hormone lev-
els, and the structure of the internal genital duct systems and external geni-
talia, derives from the platonic ideal that for each sex there is a single,
universally correct developmental pathway and outcome. We surveyed the
medical literature from 1955 to the present for studies of the frequency of
deviation from the ideal male or female. We conclude that this frequency may
be as high as 2% of live births. The frequency of individuals receiving “cor-
rective” genital surgery, however, probably runs between 1 and 2 per 1,000
live births (0.1–0.2%). Am. J. Hum. Biol. 12:151–166, 2000.
© 2000 Wiley-Liss, Inc.
Among primates, humans exhibit a mod-
est sexual dimorphism with regard to char-
acters such as body size or voice timbre
(Fedigan, 1982). With respect to sex chro-
mosome composition, gonadal structure,
hormone levels, and the structure of the in-
ternal genital duct systems and external
genitalia, however, we generally consider
Homo sapiens to be absolutely dimorphic.
Biologists and medical scientists recognize,
of course, that absolute dimorphism is a
Platonic ideal not actually achieved in the
natural world. Nonetheless, the normative
nature of medical science uses as an as-
sumption, the proposition that for each sex
there is a single, correct developmental
pathway. Medical scientists, therefore, de-
fine as abnormal any deviation from bimo-
dally distributed genitalia or chromosomal
composition (Conte and Grumbach, 1989).
If, however, one relinquishes an a priori be-
lief in complete genital dimorphism, one can
examine sexual development with an eye to-
ward variability rather than bimodality.
Conte and Grumbach (1989) list more
than 25 diagnoses affecting sexual differ-
entiation. While the incidence of some in-
dividual medical syndromes is fairly well
established, the overall frequency of inter-
sexuality is a matter of dispute. Fausto-
Sterling (1993a,b) cited a figure attributed to
John Money that the frequency of intersexu-
ality might be as high as 4% of live births, but
Money (1993) responded that he never made
such a claim. In fact, no well-documented
overview of the frequency of intersex exists at
present, and it is this lacuna that we address
in the present article. The question is of in-
terest to students of human development,
medical practitioners, and human biologists,
among others. Recently, the practice of surgi-
cally altering the genitals of intersexual in-
fants to conform to assumptions about ab-
solute dimorphism has been questioned
(Fausto-Sterling, 1995/1996; Post, 1995/
1996; Sandberg, 1995/1996; Walcutt, 1995/
1996; Diamond, 1996; Zucker, 1996; Dia-
mond and Sigmundse n, 1997 ; Kessl er,
1998). Thus, both because of a theoretical
interest in human sexual dimorphism and
medical questions about the treatment of in-
tersexuals, it is important to provide a fre-
quency baseline for the varied events which
lead to intersexuality.
We surveyed the medical literature from
1955 to the present for studies of the fre-
Contract grant sponsor: Office of University President Vartan
*Corresponde nce to: Anne Faust o-Sterling, Department of
Molecular and Cell Biology and Biochemistry, Brown Univer-
sity, Providence, RI 02912.
Received 5 November 1997; Revision received 10 December
1998; Accepted 14 December 1998
© 2000 Wiley-Liss, Inc.
PROD #M97083R2
quency of deviation from the ideal male or
female. For a few rare syndromes, we con-
sidered the literature which predates 1955.
Our sources included population surveys,
genetic studies, case surveys from indi-
vidual medical practitioners, and environ-
mental population studies. In addition to
Medline as a starting point, government
documents, bibliographies in textbooks, pre-
viously located review articles, and specific
articles provided additional sources. We did
not exclude any articles which contained
frequency estimates derived from an unse-
lected population. Rather, where appropri-
ate we indicate the limitations of particular
We define the typical male as someone
with an XY chromosomal composition, and
testes located within the scrotal sac. The
testes produce sperm which, via the vas def-
erens, may be transported to the urethra
and ejaculated outside the body. Penis
length at birth ranges from 2.5 to 4.5 cm
(Flatau et al., 1975); an idealized penis has
a completely enclosed urethra which opens
at the tip of the glans. During fetal develop-
ment, the testes produce the Mullerian in-
hibiting factor, testosterone, and dihy-
drotestosterone, while juvenile testicular
activity ensures a masculinizing puberty.
The typical female has two X chromosomes,
functional ovaries which ensure a feminiz-
ing puberty, oviducts connecting to a uterus,
cervix and vaginal canal, inner and outer
vaginal lips, and a clitoris, which at birth
ranges in size from 0.20 to 0.85 cm (Ober-
field et al., 1989). In this article, we ask how
often development meets these exacting cri-
teria for males and females.
The literature which reports the frequen-
cies of syndromes that produce intersexual-
ity varies in quality and quantity. In some
cases there are multiple surveys with large
numbers replicated over many years and in
many different geographical locations. In
others no data exist with which to estimate
frequency, while in still others the lack of
better data dictated reliance on one or a
small number of reports of uncertain qual-
ity. In each case the available data are pre-
sented. The strength or weakness of an es-
timate is also indicated.
Individuals with XXY, XO, XYY, XXYY,
XX males, and 47,XXX females comprise the
most frequently encountered deviations
from an XX (female) or XY (male) chromo-
somal make-up. An XO condition produces
individuals with female external genitalia
and streak gonads which are incapable of
fetal or pubertal gonadal hormone synthesis
and a variety of somatic alterations, while
47,XXX girls develop secondary sex charac-
teristics at puberty and are sometimes fer-
tile (Buckton, 1983). XXY individuals diag-
nosed with Klinefelter syndrome have ex-
ter n a l m ale g e n i tal i a , s mal l t e s tes ,
impaired spermatogenesis, and frequent gy-
necomastia. XXYY individuals are consid-
ered karyotypic variants of Klinefelter syn-
drome (Conte and Grumbach, 1989; Zinn et
al., 1993). XYY males are taller, on average,
than XY males, and commonly exhibit un-
derdeveloped testes (Vogel and Motulsky,
1979). Recent work, however, suggests that
many 47,XXY and 47,XYY males are undi-
agnosed because they present no symptoms
which pr ompt a ch romos omal an alysi s
(Abramsky and Chapple, 1997). The cat-
egory of XX males, which involves the trans-
location or deletion of a submicroscopic sec-
tion of the sex determining region of the Y
chromosome, is morphologically and geneti-
cally heterogeneous (Lo´pez et al., 1995).
Table 1 summarizes the results of 17
studies of the frequencies of XXYY, XX
(male), 47,XXX, and XYY individuals at
birth. The total frequency ranges from 0.002
to 2.15/1,000 live births, with a mean of
0.639/1,000 and a standard deviation of
0.665. The mean/1,000 live births and stan-
dard deviations for each of the non-XX, non-
XY chrom osome composit ions listed in
Table 1 are 0.155 (0.185) for XXYY, 0.05
(0.019) for XX males, 0.47 (0.364) for 47,
XXX, and 0.639 (0.665) for XYY.
In 24 different estimates of the frequency
of Klinefelter syndrome (XXY), the inci-
dence ranges from 0 (out of 3,890 births) to
2.13/1,000 births. The mean incidence for all
24 studies is 0.922/1,000 live births with a
standard error of 0.102 (Table 2). The 18
different estimates for the population fre-
quency of XO chromosome constitution are
shown in Table 3. The incidence ranges
from 0.0 for five small studies (sample size
of less than 3,993) to 1.67/1,000 live births.
The mean is 0.369/1,000 live births, with a
standard error of 0.111. Recent data show-
ing that not all Turner patients present
with XO identifiable by traditional karyol-
ogy suggest that the incidence calculated
from previously published studies may be
an underestimate (Zinn et al., 1993).
Androgen insensitivity in XY individuals
Disruption of fetal hormonal metabolism
in XY fetuses results most commonly from
defects in androgen receptors. Clinical fea-
tures range from a fully female external
phenotype, with a blind-ending vagina and
little axillary hair development, to a mascu-
line phenotype with azoospermia and el-
evated levels of luteinizing hormone (Griffin
and Wilson, 1989). Estimates of the fre-
quency of complete androgen insensitivity
(AIS) range from 0.049 to 0.016/1,000 male
(Bangsbøll et al., 1992; Griffin and Wilson,
1989). In addition, 1–2% of girls with ingui-
nal hernias may have androgen insensitiv-
ity (Griffin and Wilson, 1989). Jagiello and
Atwell (1962) estimate the frequency of in-
guinal hernias in girls at 8/1,000 female
births. Hence, the frequency of complete
AIS may be 0.12/1,000 female births. Aver-
aging the estimates for male births and
combining them with the estimate for fe-
male births yields a figure of 0.076/1,000
live births. There are no solid estimates of
the frequency of partial AIS, but Griffin and
Wilson (1989) suggest that it is one-tenth as
common as complete AIS. Using these esti-
mates the rate would be 0.0076/1,000 live
Griffin and Wilson (1989) cite three other
forms of AIS: 5!-reductase deficiency, Reif-
enstein syndrome and Infertile Male syn-
drome. The first two produce externally vis-
ible intersexuality, while those with Infer-
tile Male syndrome are phenotypically
male. 5-!-Reductase deficiency is quite com-
mon in a number of populations, ranging
from Central America to Vietnam (Mendoca
et al., 1996). Indeed, more than 50 families
with over 100 affected individuals have
been reported. However, no population or
gene frequencies are available (Conte and
Grumbach, 1989; Mendoca et al., 1996; Al-
TABLE 1. Incidence of XXYY, XX(male), 47,XXX and XYY births in 17 published surveys*
Location Year
Total #
surveyed XXYY XX male 47,XXX XYY
live births Method Reference
Edinburgh 1964 20,725 1 11 0.575 Bs
Maclean et al.,
Geneva 1968 8,184 1 0.122 Bs Mikamo, 1968
London 1969 2,081 4 1.922 K Sergovich et al.,
New Haven 1970 4,366 3 3 1.374 K Lubs, 1970
Toronto 1974 73,229 1 2 2 0.068 Bs/K Bell, 1974
Moscow 1974 2,500 1 0.400 K Bochkov et al.,
Winnipeg 1975 13,939 5 7
0.861 K Hamerton
et al., 1975
Ontario 1976 930 2 2.150 K Lin et al., 1976
Denver 1976 40,371 12 0.297 Bs/K Goad et al.,
USA 1977 13,751 1 0.073 K Walzer et al.,
Tokyo 1978 12,319 3 0.244 K Higurasi et al.,
Edinburgh 1979 23,196 1 11 0.517 Bs/K Ratcliffe et al.,
Edinburgh 1980 3,993 3 4 0.002 K Buckton et al.,
USA 1982 19,675 25 0.001 K Schreinemacher
et al., 1982
Telemark 1982 1,830 1 0.546 K Hansteen et al.,
Belgium 1988 77,000 32
0.416 K Kleczkowska
et al., 1988
Denmark 1991 34,910 5
2 18 20
1.289 K Nielsen, 1991
Average total/1,000 0.155 0.05 0.470 0.865 0.639
live births (SD) (0.185) (0.019) (0.364) (0.740) (0.665)
*K, karyotype. B
, buccal smear.
Excludes perinatal deaths.
Includes mosaic and nonmosaic.
Includes 25 people with more than two X chromosomes.
Includes four xx/xy mosaics.
Attia, 1996). Similarly, no such estimates
exist for Reifenstein or Infertile Male syn-
drome. Aiman and Griffin (1982) report evi-
dence of androgen resistance in more than
40% of men with no other obvious cause for
severe oligo- or azoospermia.
Congenital adrenal hyperplasia
The most common cause of intersexuality
in XX females is congenital adrenal hyper-
plasia (CAH), a label which covers a hetero-
geneous set of genetically inherited alter-
ations in steroid biosynthesis. The work on
CAH has been thoroughly reviewed (Laue
and Rennert, 1995; New et al., 1989; New-
field and New, 1997; Pang and Clark, 1990,
1993). Table 4 presents a summary. Al-
though not all forms of CAH result in am-
biguity at birth, the table includes esti-
mates for any manifestations which alter
sexually dimorphic presentation at any time
during the life cycle. The classic form of 21-
TABLE 2. Incidence of XXY births in 24 published surveys*
Location Year
Total #
live births Method Reference
Winnipeg 1959 3,715 5 0.135 Bs Moore, 1959
Bombay, India 1962 3,890 0 0 ? Subray and Prabhaker, 1962
1964 1,954 2 1.02 ? Paulsen et al., 1964
Edinburgh 1964 20,725 20 0.97 ? Maclean et al., 1964
Geneva 1968 8,184 6 0.73 ? Mikamo, 1968
London, England 1969 2,081 1 0.481 K Sergovich et al., 1969
USA 1970 3,543 5 1.411 K Gerald, 1970
New Haven 1970 4,366 4 0.916 K Lubs, 1970
Germany 1973 1,000 2 2.00 ? Golob, 1973
Dehli 1973 3,100 3 0.97 ? Verma et al., 1973
Toronto 1974 73,229 43 0.59 ? Bell, 1974
Moscow 1974 2,500 2 0.800 K Bochkov et al., 1974
Winnipeg 1975 13,939 6 0.430 K Hamerton et al., 1975
Ontario 1976 930 1 1.075 K Lin et al., 1976
Denver 1976 40,371 23 0.57 ? Goad et al., 1976
USA 1977 13,751 10 0.727 K Walzer, 1977
Edinburgh 1979 23,196 21 0.91 ? Ratcliffe et al., 1979
Tokyo 1979 12,319 2 0.162 K Higurasi et al., 1979
Edinburgh 1980 3,993 6 1.503 K Buckton et al., 1980
Telemark 1982 1,830 1 0.546 K Hansteen et al., 1982
Northeast (USA) 1982 19,675 20 1.017 K Schreinemacher et al., 1982
Germany 1984 13,168 28 2.126 K Murken, 1984
Denmark 1991 34,910 27 0.773 K Nielsen, 1991
*?, Not specified; K, karyotype; Bs, buccal smear.
Mosaic and nonmosaic.
Study reported only male births; we doubled the denominator to estimate total births.
TABLE 3. Incidence of XO births in 18 published surveys*
Location Year
Total #
surveyed Total
live births Method Reference
Edinburgh 1964 20,725 4 0.400 Bs Maclean et al., 1964
Geneva 1968 8,184 2 0.509 Bs Mikamo, 1968
London 1969 2,081 0 0 K Sergovich et al., 1969
? 1970 3,543 0 0 K Gerald, 1970
New Haven 1970 4,366 1 0.458 K Lubs, 1970
Dehli 1973 3,100 1 0.644 Bs Verma et al., 1973
Toronto 1974 73,229 5 0.141 Bs Bell, 1974
Moscow 1974 2,500 2 1.671 K Bochkov et al., 1974
Winnipeg 1975 13,939 2 0.296 K Hamerton et al., 1975
Denver 1976 40,371 27 1.370 Bs Goad et al., 1976
Ontario 1976 930 0 0 K Lin et al., 1976
Edinburgh 1979 23,196 1 0.105 Bs Ratcliffe et al., 1979
Tokyo 1979 12,319 1 0.168 K Higurasi et al., 1979
Edinburgh 1980 3,993 0 0 K Buckton et al., 1980
Telemark 1982 1,830 0 0 K Hansteen et al., 1982
New York State 1983 76,474 9 0.118 K Hook, 1983
Denmark 1991 34,910 8 0.229 K Nielsen, 1991
Mosaic and nonmosaic.
*Bs, buccal smear; K, karyotype.
hydroxylase deficiency is the most common,
and the frequency estimates are the most
reliable. Pang and Clark (1990, 1993; Pang
et al., 1988) have published detailed com-
parisons of estimates obtained from case re-
ports in large population databases, as well
as from more recentl y ava ila ble m ass
screening programs. The direct screening
programs have resulted in higher estimates
for the condition than have the more tradi-
tion al po pul ati on surveys. In both in-
stances, however, one striking fact emerges:
TABLE 4. Incidence of 21-OHase (classic) in 36 published surveys
Part A: Case surveys
Location and
subpopulation Sample size Date
live births Reference
Switzerland 1,516,299 1980 0.0646 Werder et al., 1980
France 41,073,409 1985 0.031 Bois et al., 1985
France 13,921,803 1985 0.0356 Bois et al., 1985
Switzerland 1988 0.198 Pang et al., 1988
Canada 1988 0.038 Pang et al., 1988
Austria 1988 0.111 Pang et al., 1988
US (Wisconsin) 1988 0.067 Pang et al., 1988
Switzerland 1988 0.0542 Pang et al., 1988
Hungary 27,497,606 1989 0.0023 Thompson et al., 1989
Canada 346,000 1989 0.0689 Thompson et al., 1989
Hungary 2,119,727 1988 0.033 So´lyom, 1989
Japan 585,000 1990 0.0228 Pang and Clark, 1990
Kuwait 540,000 1990 0.001 Lubani et al., 1990
Sweden 1,727,928 1990 0.0827 Thile´ n and Larsson, 1990
Israel (Jewish population) 1986–1991 0.0333 Sack et al., 1997
Israel (Arab population) 1986–1991 0.1250 Sack et al., 1997
US 1993 0.025 Pang and Clark, 1993
Average (SD) 0.0584 (0.0495)
Range 0.001–0.198
Part B: Mass screening
Alaska-Caucasian 13,733 1982 0.0728 Pang et al., 1982
Hungary 968,303 1989 0.0537 So´lyom, 1989
France (La Reunion) 31,472 1990 0.315 Pang and Clark, 1990
US (Illinois) 357,825 1990 0.0838 Pang and Clark, 1990
Portugal 100,000 1990 0.070 Pang and Clark, 1990
Scotland 119,960 1990 0.0583 Pang and Clark, 1990
Washington 255,527 1990 0.0547 Pang and Clark, 1990
Japan 2,523,948 1990 0.0223 Pang and Clark, 1990
Switzerland 65,823 1993 0.0911 Pang and Clark, 1993
Germany 12,500 1993 0.08 Pang and Clark, 1993
Italy 133,198 1993 0.09 Pang and Clark, 1993
Sweden 660,000 1993 0.0848 Pang and Clark, 1993
France (regional) 270,060 1993 0.0778 Pang and Clark, 1993
Canada 50,000 1993 0.06 Pang and Clark, 1993
Brazil 82,870 1993 0.1327 Pang and Clark, 1993
Spain 206,875 1993 0.058 Pang and Clark, 1993
Alaska-Yupik 3,740 1993 3.47 Pang and Clark, 1993
Native 12,131 1993 1.236 Pang and Clark, 1993
New Zealand 536,915 1995 0.0428 Cutfield, 1995
Texas (white) 872,648 1989–1995 0.064 Therrell et al., 1998
Texas (Hispanic) 764,101 1989–1995 0.069 Therrell et al., 1998
Texas (African American) 253,854 1989–1995 0.0236 Therrell et al., 1998
Texas (other) 46,410 1989–1995 0.1293 Therrell et al., 1998
Average for
screening (SD)
0.280 (0.738)
Without Yupik or
Native Alaskan
0.083 (0.06)
Without Yupik,
Native Alaskan,
or La Reunion
0.0709 (0.0288)
the gene frequency for 21-hydroxylase defi-
ciency varies significantly among popula-
tions. Worldwide and national estimates
must be considered in this light.
Table 4 presents data obtained from origi-
nal sources and from reviews by Pang and
Clark (1990, 1993). The average frequency
for 21-hydroxylase deficiency using case
surveys is 0.0584 ± 0.0495 and a range of
0.001–0.198/1,000 live births. The corre-
sponding statistics from mass screening
(and minus the very high incidence among
Yupik Eskimos) are 0.083 ± 0.060, and a
range of 0.0428–0.315 per 1,000 live births.
The worldwide frequencies do not include
the Yupik data (3.47/1,000 live births) and
the incidence in La Reunion, France (0.315/
1,000 live births). It does not seem obvious,
however, that it was appropriate to elimi-
nate the La Reunion data; even though the
number is high, it is in the same order of
magnitude as other data used in the calcu-
lation (e.g., Brazil). Therefore, we averaged
the numbers arrived at with and without
the La Reunion data, arriving at a world-
wide frequency of classic CAH due to 21-
hydroxylase deficiency of 0.0770/1,000 live
Tables 5 and 6 contain data concerning
the rarer enzyme deficiencies leading to
CAH. The average incidence for 3-"hydrox-
ysteroid dehydrogenase is 0.00068/1,000
live births, while that for 11-"-hydroxylase
(minus the very high frequency found in
Moroccan Jews) is 0.00362/1,000 live births
(0.00267) with a range of 0.0005–0.0071/
1,000. The one available frequency estimate
for 17-alpha hydroxylase places the number
at 7 ×10
/1,000 live births.
Finally, the unusual case of nonclassic or
late onset 21-hydroxylase deficiency needs
consideration. Nonclassic CAH is defined as
a deficiency that arises anytime after the
first 5 years of life. In childhood, such cases
may come to medical attention because of
premature signs of puberty, hirsutism, and
clitoral growth. In adults, the signs can in-
clude hirsutism, menstrual disorders, and
clitoral enlargement (Eldar-Geva et al.,
1990; Pollack et al., 1981). Speiser et al.
(1985) used estimates of gene frequencies
for late onset 21-hydroxylase deficiencies to
calculate the incidence of affected individu-
als in several different localities and ethnic
groups. While the incidence of late-onset 21-
hydroxylase varies widely among different
ethnic groups, its overall frequency is ex-
tremely high. The calculated frequencies
are 37/1,000 among Ashkenazi, 19/1,000
among Hispanics, 16/1,000 among Yugo-
slavs, 3/1,000 among Italians, and 0.01/
1,000 among a mixed Caucasian population.
Although the estimates are widely accepted
and cited (Arnaut, 1992; Eldar-Geva et al.,
1990; White et al., 1987; Newfield and New,
1997). We could not locate articles confirm-
ing the reported frequencies of Speiser et al.
(1985). Thus, while we use this estimate in
the final calculation of nondimorphism, fu-
ture reports may contain modifications of
the estimates.
Vaginal and penile agenesis
XY babies born with testes, but complete
absence of a penis, are extremely rare, prob-
ably occurring only once in a million births
(Bansal and Singh, 1990; Kumar et al.,
1986; Rupprecht et al., 1989). In contrast,
complete or partial vaginal agenesis is fairly
common. Harkins et al. (1981) report that 6
of 26 patients with vaginal agenesis had
AIS, while the remainder had M eye r-
Roki tansky- Ku¨ ster -Hauser (MRK H) syn-
drome, which is characterized by aplasia of
TABLE 5. Incidence of 11-B-hydroxylase (classic) in six published surveys
Location and
subpopulation Sample size Method
live births Reference
Switzerland 1,516,299 Case 0.0032 Werder et al., 1980
France 13,921,803 Case 0.0071 Bois et al., 1985
Hungary 2,119,727 Case 0.0018 So´lyom, 1989
Kuwait 540,000 Case 0.0055 Lubani et al., 1990
Sweden 1,727,928 Case 0.0005 Thile´ n and Larsson, 1990
Moroccan Jews Gene frequency
0.1667 Ro¨ sler et al., 1992
Mean (SD) 0.031 (0.067)
Range 0.0005–0.1667
Mean (SD) and range 0.00362 (0.00267)
without Moroccan Jews 0.0005–0.0071
the vagina, typical female secondary sexual
characteristics, attenuated fallopian tubes,
and typical ovaries and female karyotype
(Chervenak et al., 1982). To avoid “double
counting” of AIS patients, we report com-
plete estimates of vaginal agenesis inci-
dence, but in the final calculations, assume
that only 77% of these comprise an other-
wise unmeasured deviation from the usual
pathway of female development.
Unfortunately, the literature on the inci-
dence of vaginal agenesis appears more
promising than it actually is. Most articles
quote an incidence of 1/4,000 to 1/5,000
births. When one traces the citations, how-
ever, they all lead to two publications. Eng-
stad (1917, p. 330), reporting on cases en-
countered in a private practice, writes:
“From my own experience I should judge
that we might expect to find one case in
about five thousand.” Bryan et al. (1949)
note the Engstad report and cite a paper by
Owens, who reported six cases in 125,000
hospital admissions (0.048/1,000). From
their own clinical experience, Bryan et al.
(1949) estimate a frequency of 1/4,000 fe-
male patients (0.25/1,000). Currie (1974) re-
ported that between July 1969 and 1973
there were 5,189 deliveries and 2,988 gyne-
cological admissions at a USAF Medical
Center. Of the total of 8,177, there were two
records of complete or partial vaginal agen-
esis. In the most recent independent esti-
mate, Willemsen and Dony (1988) esti-
mated that 1/30,000 living Du tch-born
women have Mayer-Rokitansky syndrome.
Recognizing the limited basis of the present
knowledge of the frequency of vaginal agen-
esis, we use the figure of 1/4,500. Assuming
that 77% of these are due to unique causes,
the final incidence is 0.1694/1,000 live
births. Since congenital absence of the va-
gina can be asymptomatic, this may be an
Hormone-producing tumors and exogenous
sex hormones
Hormone-producing tumors are relatively
rare, and no population-level estimates of
incidence exist. They can, however, cause
virilization of adult women, including voice
changes, clitoral growth, and hirsutism. In
addition, they have been known to cause
fetal masculinization during pregnancy
(Hensleigh and Woodruff, 1978; Ireland and
Woodruff, 1976; Verhoeven et al., 1973). It
is also difficult to ascertain the frequency of
genital alterations caused by treatment
with progestins during pregnancy. A recent
meta-analysis of studies done on births fol-
lowing first trimester exposure to low doses
of sex hormones, especially from oral con-
traceptives, suggests little or no danger to
genital development (Raman-Wilms et al.,
1995). However, earlier studies focused on
much higher doses of progestin, used in ef-
forts to avoid miscarriage. Not only were the
doses greater in these cases, but treatment
occurred well into the second trimester of
pregnancy, a time when one might espe-
cially expect an effect on the development of
external genitalia (Steinberger and Odell,
1989). Not all progestin-treated pregnancies
result in fetal masculinization. However,
the rate for high-dose, second-trimester
treatments is probably quite high (Burstein
and Wasserman, 1974; Ishizuka et al., 1962;
Jacobson, 1962). Unfortunately, no good es-
timates exist of the number of individuals
currently living with iatrogenically induced
genital alterations. There is also no pres-
ently reliable way to know whether the
practice of treating threatened miscarriages
with progestins continues with any fre-
quency today, although the data presented
in Table 7 (section on True Hermaphrodites)
suggest that the practice has significantly
True hermaphrodites and idiopathic mixed
There are no published population-wide
estimates of the frequency of true hermaph-
rodites (individuals born with both testicu-
lar and ovarian tissue). However, a number
of surgeons and endocrinologists, who spe-
cialize in the treatment of nonconforming
TABLE 6. Incidence of rare forms of classic CAH published surveys
Location and
subpopulation Type Sample size Method
live births Reference
Switzerland 3-Beta Ohase (classic) 1,516,299 Case 0.0019 Werder et al., 1980
France 3-Beta Ohase (classic) 13,921,803 Case 0.0007 Bois et al., 1985
France 17-alpha-hydroxylase 13,921,803 Case 0.00007 Bois et al., 1985
Kuwait 3-Beta Ohase (classic) 540,000 Case 0.0055 Lubani et al., 1990
Average for 3-Beta 0.00068/1000
TABLE 7. Comparative numbers of true hermaphrodites and other forms of intersexuality
Year Hypospadias CAH
(mixed and
adenoma Reference
1960 87 71 47 3 22 Wilkins, 1960
1965 100 116 66 4 18 20 Wilkins, 1965
1967 39 5 7 1 16 Jones and
Wilkins, 1967
1974 28 6 1 Kumar et al.,
1986 19 29 7 1 1 3 11 8 Currarino, 1986
1987 0 24 8 5 6 1 14 Lobe et al., 1987
1987 4 1 2 1 1 Oesterling et al.,
1989 21 10 2 Lorge et al.,
1990 4 6 6 5 2 1 Pinter and
1991 14 1 7 3 Abdullah et al.,
1991 6 32 10 10 3 4 4 5 Coran and Z.,
1992 6 46 8 4 9 1 2 6 7 Newman et al.,
1992 12 5 7 38 9 Danso and
1993 38 23 12 Ramani
et al., 1993
1994 39(total) 4 1 Greenfield
et al., 1994
Total 442 84
% of CAH (all entries) 19% 11%
% of CAH minus rows 7 (possible duplicate) and 13 (African data) 13%
physical sex types, report on the distribu-
tion of patients. Data extracted from 14
such reports are summarized in Table 7. Al-
though different reports come from different
specialties, rendering the referral bias for
any one report great, by analyzing a large
number of such reports and making use of
the fact that the frequency of CAH is well
established, an estimate of the order of mag-
nitude of the occurrence of true hermaphro-
ditism can be obtained.
Particularly striking in Table 7 are the
data of Danso and Nkrumah (1992), who re-
ported 38 true hermaphrodites in a data-
base of 71 patients with ambiguous genita-
lia. Although the reported numbers seem in-
ordinately high, the data are consistent
with other reports suggesting high frequen-
cies of true hermaphroditism in southern
Africa (Krob et al., 1994; Ramsay et al.,
1988). In addition, some forms of true her-
maphroditism are familial (Kuhnle et al.,
1993; Skordis et al., 1987; Slaney et al.,
1998), which opens the possibility that, as
with other inherited forms of sexual ambi-
guity, there may be pockets, perhaps even
large geographical regions, with relatively
high frequencies of true hermaphroditism.
The data in Table 7 were used to estimate
the relative frequency of true hermaphrodit-
ism. First we compared the number of true
hermaphrodites summed from all 14 reports
with the number of cases of CAH (19%).
Then we considered the percentage after
eliminating the report from southern Africa,
as well as the older of two reports which
may contain duplicate data. The latter ratio
is 11% and, splitting the difference, the es-
timate of true hermaphroditism equals 15%
of the frequency of classic 21-OHase CAH.
Using a figure of 0.0779/1,000 live births for
classic CAH, the average frequency of true
hermaphroditism is on the order of 0.0117/
1,000 live births, or one in 100,000.
The data in Table 7 also allow the calcu-
lation of the frequency of idiopathic sexual
ambiguity. Using the same reasoning as for
true hermaphrodites, the birth of a sexually
ambiguous child from unknown causes is
about 0.009/1,000 live births.
This article began by asking how fre-
quently members of the human population
deviate from a Platonic ideal of sexual di-
morphism. A summary of the frequencies of
known causes of sexual ambiguity based on
Tables 1–7 appears in Table 8. The grand
total is 1.728% of live births. Because there
are no general population-level frequency
estimates for iatrogenic variations in geni-
tal anatomy, penile agenesis, and disorders
of 5-!-reductase biosynthesis and some of
the rarer forms of CAH, the data in Table 8
provide a minimal estimate. However, ex-
cept for certain restricted populations the
frequencies of such events are quite rare
and would probably not greatly influence
the overall estimate. The two most frequent
deviations from complete sexual dimor-
phism arise from nondimorphic sex chromo-
some conditions and from alterations in ste-
roid hormone metabolism. Although this
generalization holds for a generic Euro-
American, Caucasian population, it is inap-
propriate in certain geographical settings.
Thus, there is strong evidence that CAH is
very frequent among native Alaskans and
that true hermaphroditism is surprisingly
common in southern Africa. Because of the
Eurocentric nature of most medical data,
there may well be other large population
groups worldwide which exhibit substantial
frequencies of intersexuality.
TABLE 8. Frequencies of various causes of nondimorphic sexual development
Cause Estimated frequency/100 live births
Non-XX or non-XY (except Turner or Klinefelter) 0.0639
Turner 0.0369
Klinefelter 0.0922
Subtotal for chromosomal difference 0.193
Androgen Insensitivity syndrome 0.00760
Partial Androgen Insensitivity syndrome 0.000760
Classic CAH (omitting very high frequency population) 0.00770
Late-onset CAH 1.5
Subtotal of known hormonal causes 1.516
Vaginal agenesis 0.0169
True hermaphrodites 0.0012
Idiopathic 0.0009
Total 1.728
Estimates that combine categories
The approach used to estimate intersexu-
ality, at all levels, from the chromosomal
and hormonal to the anatomical, is plagued
by the uncertainties inherent in the medical
literature. Therefore, we derived a second
type of estimate from statistics on the fre-
quencies of cryptorchidism (undescended
testes) and hypospadias (the incomplete clo-
sure around the urethra of the embryonic
genital folds). These estimates serve as an
order of magnitude check of the preceding
calculations. Hypospadias and cryptorchid-
ism both result from a variety of underlying
causes of intersexuality (Aaronson et al.,
1997; Aarskog, 1971; Gearhart et al., 1990;
Gill et al., 1989; Gill and Kogan, 1997; Raj-
fer and Walsh, 1976). A U.S. Army survey in
the 1940s (Rajfer and Walsh, 1976) found
that 0.7% of the adult male population had
cryptorchidism. Scorer and Farrington
(1971) noted that the incidence of cryptor-
chidism is higher at birth and declines
throughout the first year of life to 0.8% of
male births (or roughly 0.4% of all births).
Table 9 contains an overview of the data
for hypospadias. The mean incidence of hy-
pospadias, averaged from over 20 studies
over four decades, is 1.87/1,000 live births,
with a standard deviation of 1.105 and a
range of 0.352–1.043. The data on hypospa-
dias may be further subdivided into the in-
cidence of severe and medium types (ure-
thral opening in the perineal region or along
the shaft of the penis) and minimal types
(urethral opening between the corona and
the tip of the glans penis) (Sweet et al.,
1974). Indeed Fichtner et al. (1995) have re-
cently shown widespread variation in the
meatal opening along the length of the glans
penis. The authors suggested that such
variation, sometimes classified as minimal
or mild hypospadias, is normal and surgery
in such cases unwarranted. It is difficult to
obtain absolute estimates of the rates of
minimal, medium, and severe hypospadias,
because not all publications record the data
in the same manner, and some contain nu-
merical discrepancies. Nevertheless, the ra-
tio of minimal to medium and severe hypo-
spadias is about 3:1. If, as Fichtner et al.
(1995) suggest, only medium and severe hy-
pospadias represent deviations from a di-
morphic ideal, then the incidence calculated
from cases of hypospadias would be 0.5797/
1,000, or 0.05%.
Several studies suggest that the rate of
hypospadias has increased significantly in
TABLE 9. Incidence of hypospadias
Location Date Total sample
live births Reference
Rochester, MN 1954 8,716 3.901 Harris and Steinberg, 1954
Brooklyn 1958 30,398 0.921 Shapiro et al., 1958
International 1966 416,695 0.586 Stevenson et al., 1966
Liverpool, UK 1968 91,176 1.228 Smithells, 1968
US, multiregion 1968 35,680 2.41 Chung and Myrianthopoulos, 1968
South Wales, UK 1972 92,982 1.097 Roberts et al., 1972
Sweden (general) 1973 550,000 0.949 Kallen, 1973
Sweden (Uppsala) 1973 96,733 1.158 Pettersson, 1973
Jerusalem 1973 59,261 3.004 Harlap, 1973
Athens 1973 74,390 1.949 Trichopoulos et al., 1973
Atlanta, GA 1974 137,179 2.012 CDC statistics cited in
(Avellan, 1975)
Jerusalem 1975 11,036 3.625 Harlap, 1973
Sweden 1975 480,607 1.386 Avellan, 1975
Latin American 1981 432,839 0.764 Neto and Paz, 1981
Emilia-Romagna, Italy 1986 42,156 3.985 Calzolari et al., 1986
Denmark 1986 801,241 0.975 Kallen et al., 1986
Hungary 1986 1,992,773 1.827 Kallen et al., 1986
Italy 1986 303,674 1.798 Kallen et al., 1986
Mexico 1986 162,105 0.352 Kallen et al., 1986
South America 1986 902,984 0.693 Kallen et al., 1986
Spain 1986 334,970 1.797 Kallen et al., 1986
Sweden 1986 896,954 2.085 Kallen et al., 1986
Alsace, France 1990 118,265 1.488 Stoll et al., 1990
Atlanta, GA 1993 ? 3.0 Paulozzi et al., 1997
USA 1993 ? 3.8 Paulozzi et al., 1997
Mean 1.87 SD 1.105 Range: 0.352–3.985
the past two decades (Paulozzi et al., 1997;
Toppari et al., 1996; Kristensen et al., 1997).
Furthermore, severe hypospadias seems to
have increased at a more rapid rate than
the mild form, and there are both regional
(within the U.S.) and national differences in
overall rates of hypospadias, as well as in
the rate of increase. While the cause of such
increases is currently unknown, such trends
mean that current estimates of the rate of
intersexual births may require revision
with time.
Adding the estimates of all known causes
of nondimorphic sexual development sug-
gests that approximately 1.7% of all live
births do not conform to a Platonic ideal of
absolute sex chromosome, gonadal, genital,
and hormonal dimorphism. The incidence of
hypospadias (0.05%) and cryptorchidism
(0.4%), conditions of mixed origin affecting
the apparently male population, are lower
than the present estimate. However, the
calculation includes categories which result
in neither hypospadias nor cryptorchidism.
The single largest contribution to the higher
figure comes from late-onset CAH. If this
cause of nondimorphism is deleted, the fre-
quency estimates obtained from population
surveys would come to 0.228%, the same or-
der of magnitude found after combining the
incidences of severe and medium hypospa-
dias and cryptorchism (0.05 + 0.4 !0.45%).
Alternatively, if mild hypospadias and late-
onset CAH in the final calculations are in-
cluded the combined figure is 2.27% for hy-
pospadias and cryptorchidism, compared
with 1.728% obtained from summing the in-
cidence of all known causes for which avail-
able data exist. These data, obtained using
independent methods, are in general agree-
ment. Which number one chooses to use de-
pends on the specific population under
study, and the assumptions as to what
should count as true dimorphism. It would
appear, however, that earlier estimates that
intersexual births might run as high as 4%
are unwarranted, except in populations in
which a particular genetic condition occurs
wi th hig h freq uenc y (Fau sto- Ster ling ,
1993a,b; Money, 1993).
Recently, a nascent social movement to
recognize intersexuality as a legitimate
state of nature has criticized medical ap-
proaches to the management of intersexual-
ity (Nevada and Chase, 1995; Kessler, 1998)
and these criticisms have begun to appear
in more traditional medical settings (Dia-
mond and Sigmundsen, 1997; Phornphut-
kul et al., 1999). Members of the Intersex
Society of North America oppose the use of
genital surgery to “normalize” children who
are too young to decide for themselves
whether to modify their genital structures.
We define the intersexual as an individual
who deviates from the Platonic ideal of
physical dimorphism at the chromosomal,
genital, gonadal, or hormonal levels. Not all
intersexuals would be candidates for genital
surgery. Lilford and Dear (1987) suggest
that 0.05% (1 in 2,000) newborns have some
ambiguity of the external genitalia, al-
though they cite no medical or scientific lit-
erature to back up their claim. As one might
expect, even given the data in Table 8, esti-
mating the number of children subject to
controversial genital surgery is an uncer-
tain business. Turner and Klinefelter syn-
dromes do not usually call for surgical in-
tervention. However, many, although prob-
ably not all, of the other chromosomal
alterations do, since they often result in in-
termediate genital development (Mittwoch,
1992). All of the hormonal disruptions po-
tentially cause conditions which have been
treated surgically. The highest frequency of
intersexuality comes from late-onset CAH.
When late-onset CAH occurs in childhood or
adolescence and causes significant clitoral
growth, it is quite possible that surgical in-
tervention will ensue (Moreno and Goodwin,
1998). However, there is no way to estimate
what proportion of late-onset CAH patients
fall into this subcategory. Combining chro-
mosomal deviations other than Turner or
Klinefelter, all hormonal alterations, vagi-
nal agenesis, true hermaphrodites, and id-
iopathic genital intersex, produces an esti-
mate that 1.62% of the population may be
subject to genital surgery as a treatment for
intersexuality. Without late-onset CAH in
this calculation, the estimate falls to 0.08%,
or between one and two in a thousand. The
true frequency of such surgeries probably
lies somewhere in between.
Our culture acknowledges the wide vari-
ety of body shapes and sizes characteristic
of males and females. Most sexual dimor-
phisms involve quantitative traits, such as
height, build, and voice timbre, for which
considerable overlap exists between males
and females. Many cultures use dress code,
hair style, and cultural conventions, e.g.,
Fig. 1. (A) Absolute dimorphism; (B) incomplete dimorphism.
the view that in couples the male should be
taller than the female, to accentuate aware-
ness of such difference (see Unger and
Crawford, 1992). But most consider that at
the level of chromosomes, hormones, and
genitals, dimorphism is absolute and, by im-
plication, such traits are discrete rather
than quantitative. Clearly, as a generaliza-
tion, such a viewpoint makes some sense.
However, developmental biology suggests
that a belief in absolute sexual dimorphism
is wrong. Instead, two overlapping bell-
shaped curves can be used to conceptualize
sexual variation across the population (Fig.
1). Within each major bell, genital morphol-
ogy varies quantitatively, as shown, for ex-
ample, by Fichtner et al. (1995). In the re-
gion of overlap, qualitative variation in
chromosomal and genital morphology and
in hormonal activity exists. If the view of
the human population schematically illus-
trated in Figure 1B is accepted, the require-
ment for medical intervention in cases of in-
tersexuality needs to be carefully reexam-
ined. It seems likely that changing cultural
norms concerning sex roles and gender-
related behaviors may encourage a willing-
ness to engage in such a reexamination.
We acknowledge a support grant from the
office of University President Vartan Grego-
rian to Anthony Ch aruvastra, an d the
strong system of undergraduate/faculty col-
laboration supported by the Brown Univer-
sity curricular structure.
Aaronson IA, Murat CA, Key LL. 1997. Defects of the
testosterone biosynthetic pathway in boys with hypo-
spadias. J Urol 157:1884–1888.
Aarskog D. 1971. Intersex conditions masquerading as
simple hypospadias. Birth Defects Orig Artic Ser 7:
Abdu ll ah MA , Ka tu gam po la M, A l- Ha bib S , Al -
Jurayyan N, Al-Sammarrai A, Al-Nuaim A, Patel PJ,
Niazi M. 1991. Ambiguous genitalia: medical, socio-
cultural and religious factors affecting management
in Saudi Arabia. Ann Trop Paediatr 11:343–348.
Abramsky L, Chapple J. 1997. 47,XXY (Klinefelter syn-
drome) and 47,XYY: estimated rates of and indication
for postnatal diagnosis for prenatal counseling. Pre-
nat Diagn 17:363–368.
Aiman J, Griffin JE. 1982. The frequency of androgen
receptor deficiency in infertile men. J Clin Endocrinol
Metab 54:725–732.
Al-Attia HM. 1996. Gender identity and role in a pedi-
gree of Arabs with intersex due to 5-alpha reductase-2
deficiency. Psychoneuroendocrinology 21:651–657.
Arnaut MA. 1992. Late onset congenital adrenal hyper-
plasia in women with hirsutism. Eur J Clin Invest
Avellan L. 1975. The incidence of hypospadias in Swe-
den. Scand J Plast Reconstr Surg 9:129–139.
Bangsbøll S, Qvist I, Lebech PE, Lewinsky M. 1992.
Testicular feminization syndrome and associated go-
nada l tumors in Denm ark . Acta Obstet Gy necol
Scand 71:63–66.
Bansal RK, Singh J. 1990. Congenital absence of the
penis. Indian Pediat 27:882–884.
Bell AG, PN Corey. 1974. A sex chromatin and Y body
survey of Toronto newborns. Can J Genet Cytol 16:
Bochkov NP, Chebotarev AN, Alekhin VI, Midian SA.
1974. Population cytogenetic investigation of new-
borns in Moscow. Humangenetik 22:139–152.
Bois E, Mornet E, Chompret A, Feingold J, Hochez J,
Goulet V. 1985. L’hyperplasie congenitale des surre-
nales (21-0H) en France (21-OH congenital adrenal
hyperplasia in France). Arch French Pediatr 42:175–
Bryan A, Nigro J, Counseller V. 1949. 100 cases of con-
genital absence of the vagina. J Surg Gynecol Obstet
Buckton KE. 1983. Incidence and some consequences of
X-chromosome abnormalities in liveborn infants: cy-
togenetics of the mammalian X Chromosome. Part B:
X chromosome abnormalities and their clinical mani-
festations. New York: Alan R. Liss. p 7–22.
Buck ton KE, O’Rior dan ML, Ratcli ffe S, Slight J,
Mitchell M, McBeath S, Keay AJ, Barr D, Short M.
1980. A G-band study of chromosomes in liveborn in-
fants. Ann Hum Genet 43:227–239.
Burstein R, Wasserman HC. 1974. The effect of provera
on the fetus. Obstet Gynecol 23:931–934.
Calzolari E, Contiero RM, Roncarati E, Mattiuz PL, Vol-
pato S. 1986. Aetiological factors in hypospadias. J
Med Genet 23:333–337.
Chervenak FA, Stangel JJ, Nemec M, Amin HK. 1982.
Mayer-Rokitansky-Kuster-Hauser syndrome: congen-
ital absence of vagina. NY State J Med 82:23–26
Chung CS, Myrianthopoulos NC. 1968. Racial and pre-
natal factors in major congenital malformation. Am J
Hum Genet 20:44–60.
Conte FA, Grumbach MM. 1989. Pathogenesis, classifi-
cation, diagnosis and treatment of anomalies of sex.
In: de Groot L, editor. Endocrinology. New York:
Saunders. p 1810–1847.
Coran AG, Polley TZ Jr. 1991. Surgical management of
ambiguous genitalia in the infant and child. J Pediatr
Surg 26:812–820.
Currarino G. 1986. Large prostatic utricles and related
structures, urogenital sinus and other forms of ure-
throvaginal confluence. J Urol 136:1270–1279.
Currie JL. 1974. Asymptomatic Mullerian anomalies.
Med Ann DC 43:18–21.
Cutfield WS, Webster D. 1995. Newborn screening for
congenital adrenal hyperplasia in New Zealand. J Pe-
diat 126:118–121.
Danso AP, Nkrumah FK. 1992. The challenges of am-
biguous genitalia. Cent Afr J Med 38:367–371.
Diamond, M. 1996. Prenatal predisposition and the
clinical management of some pediatric conditions. J
Sex Marital Ther 22:139–147.
Diamond M, Sigmundsen K. 1997. Management of in-
tersexuality: guidelines for dealing with persons with
ambiguous genitalia. Arch Pediatr Adolesc Med 151:
Eldar-Geva T, Hurwitz A, Vecsei P, Palti Z, Milwidsky
A, Ro¨sler A. 1990. Secondary biosynthetic defects in
women with late-onset congenital adrenal hyperpla-
sia. N Engl J Med 323:855–863.
Engstad JE. 1917. Artificial vagina. Lancet 15:336.
Fausto-Sterling A. 1993a. The five sexes: why male and
female are not enough. Sciences March/April:20–24.
Fausto-Sterling A. 1993b. Reply. Sciences June/July:4.
Fausto-Sterling A. 1995/1996. Time to re-examine old
treatment paradigms. Hermaphrodites with Attitude
Fedigan LM. 1982. Primate paradigms: sex roles and
social bonds. Montreal: Eden Press.
Fichtner J, Filipas D, Mottrie AM, Voges GE, Hohen-
fellner R. 1995. Analysis of meatal location in 500
men: wide variation questions need for meatal ad-
vanc ement in all pediat ric a nterior hypo spa dias
cases. J Urol 154:833–834.
Flatau E, Josefsberg Z, Reisner SH, Bialik O, Laron Z.
1975. Penile size in the newborn infant. J Pediatr
Gearhart JP, Donohoue PA, Brown TR, Walsh PC,
Berkovitz GD. 1990. Endocrine evaluation of adults
with mild hypospadias. J Urol 144:274–277.
Gerald PS, Walzer S. 1970. Chromosome studies of nor-
mal newborn infants. In: Jacobs PA, Price WH, Law
P, editors. Human population genetics. Edinburgh:
Edinburgh University Press. p 144–151.
Gill B, Kogan S. 1997. Cryptorchidism: current con-
cepts. Pediatr Urol 44:1211–1227.
Gill B, Kogan S, Starr S, Reda E, Levitt S. 1989. Sig-
nificance of epididymal and ductal anomalies associ-
ated with testicular maldescent. J Urol 142:556–558.
Goad WB, Robinson A, Puck TT. 1976. Incidence of an-
euploidy in a human population. Am J Hum Genet
Golob E, Wagenbichler P. 1973. Geschlechtschromatin
und fluoeszenzkorperchen von 1000 Neugeborenen.
Geburts Frauenheilk 33:86–92.
Greenfield SP, Sadler BT, Wan J. 1994. Two-stage re-
pair for severe hypospadias. J Urol 152:498–501.
Griffin JE, Wilson JD. 1989. The androgen resistance
syndromes: 5-alpha reductase deficiency, testicular
feminization and related disorders. In: Scriver CR,
Beaudet AL, Sly WS, Valle D, editors. The metabolic
basis of inherited disease. New York: McGraw Hill. p
Hamerton JL, Canning N, Smith RM. 1975. A cytoge-
netic survey of 14,069 newborn infants. Clin Genet
Hansteen I-L, Varslot K, Steen-Johnsen J, Langard S.
1982. Cytogenetic screening of a new-born population.
Clin Genet 21:309–314.
Harkins JL, Gysler M, Cowell CA. 1981. Anatomical
amenorrhea: the problems of congenital vaginal agen-
esis and its surgical correction. Pediatr Clin N Am
Harlap S, Davis AM. 1973. Epidemiology of hypospa-
dias. Br Med J 4(5886):235.
Harris LE, Steinberg AG. 1954. Abnormalities observed
during the first six days of life in 8716 live-born in-
fants. Pediatrics 14:314–326.
Hensleigh PA, Woodruff DA. 1978. Differential mater-
nal-fetal response to androgenizing luteoma or hyper-
reactio luteinalis. Obstet Gynecol Surv 33:262–271.
Higurasi M, Iijima K, Ishikawa N, Hoshina H, Watan-
abe N. 1979. Incidence of major chromosome aberra-
tions in 12,319 newborn infants in Tokyo. Hum Genet
Hook EB, Warburton D. 1983. The distribution of chro-
moso mal genotypes ass oci ated with Turn er sy n-
drome: live birth prevalence rates and evidence for
diminished fetal mortality and severity in genotypes
associated with structural X abnormalities or mosa-
icism. Hum Genet 64:24–27.
Ireland K, Woodruff JD. 1976. Masculinizing ovarian
tumors. Obstet Gynecol Surv 31:83–111.
Ishizuka N, Kawashima Y, Nakanishi T. 1962. Statis-
tical observations on genital anomalies of newborns
following the administration of progestins to their
mothers. J Japan Obstet Gynecol Soc 9:271–282.
Jacobson B. 1962. Hazards of norethindrone therapy
during pregnancy. Am J Obstet Gynecol 84:962–968.
Jagiello G, Atwell JD. 1962. Prevalence of testicular
feminisation. Lancet 1:329.
Jones HWJ, Wilkins L. 1967. Gynecological operations
in 94 patients with intersexuality. Am J Obstet Gy-
necol 82:1142–1153.
Kallen B, Winberg J. 1973. The Swedish register of con-
genital malformations 1965–1971. Stockholm: Swed-
ish Board of Health and Welfare.
Kallen B, Bertollini R, Castilla E, Czeizel A, Knudsen
LB, Martinez-Frias ML, Mastroiacovo P, Mutchinick
O. 1986. A joint international study on the epidemi-
ology of hypospadias. Acta Paediatr Scand (Suppl)
Kessler S. 1998. Lessons from the intersexed. New
Brunswick, NJ: Rutgers University Press.
Kleczkowska A, Jean-Pierre F, Van den Berghe H.
1988. X-chromosome polysomy in the male. Hum
Genet 80:16–22.
Kristensen P, Irgens LM, Andersen A, Bye AS, Sund-
heim L. 1997. Birth defects among offspring of Nor-
wegian farmers 1967–1991. Epidemiology 8:537–544.
Krob G, Braun A, Kuhnle U. 1994. True hermaphrodit-
ism: geographical distribution, clinical findings, chro-
mosomes and gonadal histories. Eur J Pediatr 153:2–
Kuhnle U, Schwarz HP, Lo¨hrs U, Stengel-Ruthkowski
S, Cleve H, Braun A. 1993. Familial true hermaphro-
ditism: paternal and maternal transmission of true
hermaphroditism (46,XX) and XX maleness in the ab-
sence of Y-chromosomal sequences. Hum Genet 92:
Kumar H, Kiefer JH, Rosenthal IE, Clark SS. 1974.
Clitoroplasty: experience during a 19-year period. J
Urol 111:81–84.
Kumar A, Wakhlu AK, Chandra H. 1986. Congenital
absence of the penis. Indian Pediatr 23:303–304.
Laue L, Rennert OM. 1995. Congenital adrenal hyper-
plasia: molecular genetics and alternative approaches
to treatment. Adv Pediatr 42:113–143.
Lilford RJ, Dear PRF. 1987. The intersex baby. Br J
Hosp Med 37:28–34.
Lin CC, Gedeon MM, Griffith P, Smink WK, Newton
DR, Wilkie L, Sewall LM. 1976. Chromosome analysis
on 930 consecutive newborn children using quina-
crine fluorescent banding technique. Hum Genet 31:
Lobe TE, Woodall DL, Richards GE, Cavallo A, Meyer
WJ. 1987. The complications of surgery for intersex:
changing patterns over two decades. J Pediatr Surg
Lo´pez M, Torres L, Mendez JP, Cervantes A, Pe´rez-
Palacios G, Erickson RP, Alfaro G, Kofman-Alfaro S.
1995. Clinical traits and molecular findings in 46,XX
males. Clin Genet 48:29–34.
Lorge F, Wese FX, Sluysmans T, Hennebert PN, Mal-
vaux P, Maes M, Claus D, Capuyt P, Opsomer RJ,
Van Cangh PJ. 1989. L’ambiguı¨te´ sexuelle: aspects
urologiques. Acta Urol Belg 57:1989.
Lubani MM, Issa A-RA, Al-Saleh QA, Dudin KI, Reavey
PC, El-Khalifa MY, Manandhar DS, Abdul-Al YK, Is-
mail EA, Teebi AS. 1990. Prevalence of congenital
adrenal hyperplasia in Kuwait. Eur J Pediatr 149:
Lubs HA, Ruddle, FH. 1970. Chromosomal abnormali-
ties in the human population: estimation of rates
based on New Haven newborn study. Science 169:
Maclean N, Harnden DG, Court Brown WM, Bond J,
Mantle DJ. 1964. Sex-chromosome abnormalities in
newborn babies. Lancet 1:286–290.
Mendoca BB, Inacio M, Costa EMF, Arnhold IJP, Silva
FAQ, Nicolau W, Bloise W, Russell DW, Wilson JD.
1996. Male pseudohermaphroditism due to steroid
5!-reductase 2 deficiency. Medicine 75:64–75.
Mikamo K. 1968. Sex chromosomal anomalies in new-
born infants. Obstet Gynecol 32:688–699.
Mittwoch U. 1992. Sex determination and sex reversal:
genotype, phenotype dogma and semantics. Hum
Genet 89:467–479.
Money J. 1993. Letter to the editor. Sciences June/July:4.
Moore KL. 1959. Sex reversal in newborn babies. Lan-
cet 1:217–219.
Moreno A, Goodwin J. 1998. Am I a woman or a man?
Mademoiselle March:178–181, 208.
Murken J, Stengel-Rukowsky. 1984. Klinefelter syn-
drome in prenatal diagnosis: incidence and conse-
quences for genetic counseling. In: Bandmann HJ,
Breit R, editors. Klinefel te r sy nd ro me . Be rl in :
Springer-Verlag. p 25–28.
Neto RM, Castilla EE, Paz JE. 1981. Hypospadias: an
epidemiological study in Latin America. Am J Med
Genet 10:5–19.
Nevada E, Chase C. 1995. Natural allies. Hermaphro-
dites with Attitude Summer:1–ff11.
New MI, White PC, Pang S, DuPont B, Speiser PW.
1989. The adrenal hyperplasias. In: Scriver C et al.,
editors. The metabolic basis of inherited disease. New
York: McGraw-Hill. p 1881–1917.
Newfield RS, New MI. 1997. 21-Hydroxylase deficiency.
Ann NY Acad Sci 816:219–229.
Newman K, Randolph J, Anderson K. 1992. The surgi-
cal management of infants and children with ambigu-
ous genitalia. Ann Surg 215:644–653.
Nielsen J, Mogens W. 1991. Chromosome abnormalities
found among 34910 newborn children: results from a
13 year incidence study in Arhus, Denmark. Hum
Genet 87:81–83.
Oberfield SE, Mondok A, Shahrivar F, Klein JE, Levine
LS. 1989. Clitoral size in full-term infants. Am J Peri-
nat 6:453–454.
Oesterling JE, Gearhart JP, Jeffs RD. 1987. A unified
approach to early reconstructive surgery of the child
with ambiguous genitalia. J Urol 138:1079–1084.
Pang S, Clark A. 1990. Newborn screening, prenatal
diagnosis, and prenatal treatment of congenital adre-
nal hyperplasia due to 21-hydroxylase deficiency.
Trends Endocrinol Metab 1:300–307.
Pang S, Clark A. 1993. Congenital adrenal hyperplasia
due to 21-hydroxylase deficiency: newborn screening
and its relationship to the diagnosis and treatment of
the disorder. Screening 2:105–139.
Pang S, Murphey W, Levine LS, Spence DA, Leon A,
LaFranchi S, Surve AS, New MI. 1982. A pilot new-
born screening program for congenital adrenal hyper-
plasia in Alaska. J Clin Endocrinol Metab 55:413–420.
Pang S, Wallace MA, Hofman L, Thuline HC, Dorche C,
Lyon ICT, Dobbins RH, Kling S, Fujieda K, Suwa S.
1988. Worldwide experience in newborn screening for
classical congenital adrenal hyperplasia due to 21-
hydroxylase deficiency. Pediatrics 81:866–874.
Paulozzi LJ, Erickson JD, Jackson RJ. 1997. Hypospa-
dias trends in two US surveillance systems. Pediat-
rics 100:831–834.
Paulsen CA, De Souza A, Yoshizumi T, Lewis BM. 1964.
Results of a buccal smear survey in noninstitutional-
ized adult males. J Clin Endocrinol 24:1182–1187.
Pettersson F, Smedby B. 1973. In-patient statistics
from hospitals in the Uppsala region 1964-1968. New
born infants. Stockholm: Swedish Board of Health
and Welfare, Reports, 12:1–21.
Phornphutkul C, Fausto-Sterling A, Gruppuso P. Gen-
der self-reassignment in an XY adolescent male born
with ambiguous genitalia. Pediatrics (in press).
Pinter A, Koxatolanyi G. 1990. Surgical management of
neonates and children with ambiguous genitalia. Acta
Paediatr Hung 30:111–121.
Pollack MS, Levine LS, O’Neill GJ, Pang S, Lorenzen F,
Kohn B, Rondanini GF, Chiumello G, New MI, Du-
pont B. 1981. HLA linkage and B14,DR1,BfS haplo-
type association with the genes for late onset and
cryptic 21-hydroxylase deficiency. Am J Hum Genet
Post L. 1995/1996. Physicians: intersexual adults have
much to teach you. Hermaphrodites with Attitude
Rajfer J, Walsh PC. 1976. The incidence of intersexual-
ity in patients with hypospadias and cryptorchidism.
J Urol 116:769–770.
Ramani P, Yeung CK, Habeebu SSM. 1993. Testicular
intratubular germ cell neoplasia in children and ado-
lescents with intersex. Am J Surg Pathol 17:1124–1133.
Raman-Wilms L, Tseng AL-i, Wighardt S, Einarson TR,
Koren G. 1995. Fetal genital effects of first-trimester
sex hormone exposure: a meta-analysis. Obstet Gyne-
col 85:141–149.
Ramsay M, Bernstein R, Zwane E, Page DC, Jenkins T.
1988. XX true hermaphroditism in Southern African
Blacks: an enigma of primary sexual differentiation.
Am J Hum Genet 43:4–13.
Ratcliffe SG, Axworthy D, Ginsborg A. 1979. The Edin-
burgh study of growth and development in children
with sex chromosome abnormalities. Birth Defects
Orig Artic Ser 15:243–260.
Roberts CJ, Lowe CR, Lloyd S. 1972. Cyclic variations
in date of last menstrual period of mothers of infants
with congenital malformations in South Wales, 1964–
1966. Br J Prevent Soc Med 26:212–218.
Ro¨sler A, Esther L, Cohen T. 1992. High frequency of
congenital adrenal hyperplasia (classic 11-beta hy-
droxylase deficiency) among Jews from Morocco. Am J
Med Genet 42:827–834.
Rupprecht T, Deeg KH, Bohles HJ. 1989. Penisagen-
esie. Klin Padiatr 201:409–411.
Sack J, Front H, Kaiserman I, Schreiber M. 1997. 21-
Hydroxylase deficiency: screening and incidence in Is-
rael. Horm Res 48:115–119.
Sandberg D. 1995/1996. A call for clinical research. Her-
maphrodites with Attitude Winter:8–9.
Schreinemacher DM, Cross PK, Hook EB. 1982. Rates
of trisomies 21, 18, 13 and other chromosome abnor-
malities in about 20,000 prenatal studies compared
with estimated rates in live births. Hum Genet 61:
Scorer CG, Farrington GH. 1971. Congenital deformi-
ties of the testis and epididymis. New York: Appleton-
Sergovich F, Valentine GH, Chen ATL, Kinch RAH,
Smout MS. 1969. Chromosome aberrations in 2159
consecutive newborn babies. N Engl J Med 280:851–
Shapiro RN, Eddy W, Fitzgibbon J, O’Brien G. 1958.
The incidence of congenital anomalies discovered in
the neonatal period. Am J Surg 96:396–400.
Skordis NA, Stetka DG, MacGillivray MH, Greenfield
SP. 1987. Familial 46,XX males coexisting with famil-
ial 46,XX hermaphrodites in same pedigree. J Pediatr
Slaney SF, Chalmers IJ, Affara, NA Chitty, LS. 1998.
An autosomal or X-linked mutation results in true
hermaphrodites and 46,XX males in the same family.
J Med Genet 35:17–22.
Smithells RW. 1968. Incidence of congenital abnormali-
ties, 1960-1964. Br J Prevent Soc Med 22:36–37.
So´lyom J, Hughes IA. 1989. Value of selective screening
for congenital adrenal hyperplasia in Hungary. Arch
Dis Child 64:338–342.
Speiser PW, Dupont B, Rubinstein P, Piazza A, Kaste-
lan A, New MI. 1985. High frequency of nonclassical
steroid 21-hydroxylase deficiency. Am J Hum Genet
Steinberger E, Odell WD. 1989. Genetics, anatomy and
fetal endocrinology. In: de Groot L, editor. Endocri-
nology. 2nd ed. New York: Saunders. p 1801–1809
Stevenson AC, Johnston HA, Stewart MIP, Golding DR.
1966. Congenital malformations: a report of a study of
series of consecutive births in 24 centres. Bull WHO
(Suppl) 34:66–69.
Stoll C, Alembik Y, Roth MP, Dott B. 1990. Genetic and
environmental factors in hypospadias. J Med Genet
Sub ray NN, P rabha ke r SN. 196 2. Sex ch ro matin
anomalies in newborn babies in India. Science 136:
Sweet RA, Schrott HG, Kurland R, Culp DS. 1974.
Study of the incidence of hypospadias in Rochester,
Minnesota, 1950–1970, and a case-control comparison
of possible etiologic factors. Mayo Clin Proc 49:52–59.
Therrell BL, Berenbaum SA, Manter-Kapanke V, Sim-
mank J, Korman K, Prentice L, Gonzalez J, Gunn S.
1998. Results of screening 1.9 million Texas newborns
for 21-hydroxylase-deficient congenital adrenal hy-
perplasia. Pediatrics 101:583–590.
Thile´n A, Larsson A. 1990. Congenital adrenal hyper-
plasia in Sweden, 1969-1986. Acta Paediatr Scand 79:
Thompson R, Seargeant L, Winter JSD. 1989. Screening
for congenital adrenal hyperplasia: distribution of
17alpha hydroxyprogesterone concentrations in neo-
natal blood spot specimens. J Pediatr 114:400–404.
Toppari J, Larsen JC, Christiansen P, Giwercman A,
Gran djean P, Guile tte LJ, Jegou B, J ensen TK,
Jouannet P, Keiding N, Leffers H, McLachlan JA,
Meyer O, Mu¨ ller J, Rajpert-DeMeyts E, Scheike T,
Sharpe R, Sumpter J, Skakkebaek NE. 1996. Male
reproductive health and environmental estrogens.
Environ Health Perspect 104(Suppl 4):741–803.
Trichopoulos D, Cadas C, Kalapothaki V, Pimenidou E.
1973. Epidemiology of hypospadias. Br Med J 4:109.
Unger R, Crawford M. 1992. Women and gender: a femi-
nist psychology. New York: McGraw Hill.
Verhoeven ATM, Mastboom JL, Van Leusden HAIM,
Van der Velden WHM. 1973. Virilization in preg-
nancy coexisting with an (ovarian) mucinous cystad-
enoma: a case report and review of virilizing ovarian
tumors in pregnancy. Obstet Gynecol Surv 28:597–
Verma IC, Bawa B, Chai OP, Guaha DK. 1973. Survey
of X chromatin aberrations in newborn babies in
Delhi. Indian Pediatr 10:537.
Vogel F, Motulsky AG. 1979. Human genetics: problems
and approaches. Berlin: Springer-Verlag.
Walcutt H. 1995/1996. Physically screwed by cultural
myth: the story of a Buffalo Children’s Hospital sur-
vivor. Hermaphrodites with Attitude Winter:10–13.
Walzer S, Park G. 1977. A chromosome survey of 13751
male newborns. In: Hook EB, Porter IH, editors.
Population cytogenetics: studies in humans. New
York: Academic Press. p 45.
Werder EA, Siebenmann RE, Knorr-Murset G, Zimmer-
mann A, Sizonenko PC, Theintz P, Girard J, Zach-
mann M, Prader A. 1980. The incidence of congenital
adrenal hyperplasia in Switzerland—a survey of pa-
tients born in 1960–1974. Helv Paediatr Acta 35:5–
White PC, New MI, DuPont B. 1987. Congenital adre-
nal hyperplasia. N Engl J Med 316:1519–1524.
Wilkins L. 1960. Abnormalities of sex differentiation:
classification, diagnosis, selection of gender of rearing
and treatment. Pediatrics 26:846–857.
Wilkins L. 1965. Abnormal sex differentiation: her-
maphroditism and gonadal dysgenesis. In: The diag-
nosis and treatment of endocrine disorders in child-
hood and adolescence. 3rd ed. Springfield, IL: Charles
C. Thomas. p 297–338.
Willemsen WNP, Dony JMJ. 1988. Een decennium er-
varing met de behandeling van hypo-en aplasie van
de vagina met de neovaginaplastiek volgens Davydov
en met de (niet-operatieve) method van Frank. Ned-
erlandse Tijdschrift voor Geneeskunde 132:1199–
Zinn AW, Page DC, Fisher EMC. 1993. Turner syn-
drome : the case of the missing sex chrom osome.
Trends Genet 9:90–93.
Zucker KJ. 1996. Commentary on Diamond’s “Prenatal
predisposition and the clinical management of some
pediatric conditions.” J Sex Marital Ther 22:148–160.
... The scientific consensus around sex and gender has evolved in the past decades [Nature Editors 2018]. As surveyed by Fausto-Sterling [2012], sex is not one but a combination of many biological classifications (chromosomal, hormonal, reproductive, ...) which cannot be assigned in a binary way to one in 50 people [Blackless et al. 2000]. Gender refers to an individual's self-identity [Money and Ehrhardt 1972], their performance as shaped by social expectations [Butler 2003], or organizational structures that segregate people into, e.g. ...
Full-text available
We survey the treatment of sex and gender in the Computer Graphics research literature from an algorithmic fairness perspective. The established practices on the use of gender and sex in our community are scientifically incorrect and constitute a form of algorithmic bias with potential harmful effects. We propose ways of addressing these as technical limitations.
... 452). This view is corroborated by findings on the biological development of sexual markers (Fausto-Sterling 2000 showing how typically feminine and masculine genitalia are just two extremes of a variegated spectrum of possible configurations (see also Blackless et al. 2000) with respect to chromosomal, gonadal, hormonal, and genital sex. ...
Full-text available
The notion of politicization has been often assimilated to that of partisanship, especially in political and social sciences. However, these accounts underestimate more fine-grained, and yet pivotal, aspects at stake in processes of politicization. In addition, they overlook cognitive mechanisms underlying politicizing practices. Here, we propose an integrated approach to politicization relying on recent insights from both social and political sciences, as well as cognitive science. We outline two key facets of politicization, that we call partial indetermination and contestability, and we show how these can be accounted for by appealing to recent literature in cognitive science concerned with abstract conceptual knowledge. We suggest that politicizing a concept often implies making its more abstract components more salient, hence legitimating its contestable character. Finally, we provide preliminary suggestions to test our proposal, using the concept of gender as case study.
... Although biological sex is often thought of as a male and female binary, intersex and hormonal variations occur in individuals, such that sex may similarly be considered across a spectrum. 4 Gender refers to a sociocultural construct consisting of the norms, behaviours and roles associated with a specific gender within a specific culture. Within Western traditions, it is thought to be a binary between women and men, 5 but many First Nations and non-Western cultures encompass broader gender diversity. ...
... Such inclusive terminology (i.e., AFAB/AMAB) importantly reflects that sex is mutable, that there may be a discordance between assigned and self-identified sex, and that, ultimately, we do not know how decedents self-identified. However, sex is not binary, and numerous chromosomal combinations exist beyond the female/male typology, resulting in an estimated 2% of individuals being intersex [54]. While not the subject of the present study, the term "intersex" is used to describe persons with innate sex characteristics that emerge during embryological development and fall outside conventional conceptions of AFAB or AMAB bodies [53]. ...
Full-text available
Abstract: Methods for estimating assigned, binary sex at birth from skeletonized remains have primarily been developed for specific population groups in the U.S. (e.g., African American, European American, Hispanic) and, thus, inherently rely on ancestry estimation as a foundational component for constructing the biological profile. However, ongoing discussions in forensic anthropology highlight pressing issues with ancestry estimation practices. Therefore, this research provides population-inclusive assigned-sex estimation models for cases where ancestry is not estimated or is truly unknown. The study sample (n = 431) includes 3D volume-rendered skull computed tomography scans from the novel New Mexico Decedent Image Database of African, Asian, European, Latin, and Native Americans. Five standard nonmetric traits were scored, and eighteen standard measurements were obtained. Binary logistic regressions and discriminant function analyses were employed to produce models and classification accuracies, and intraobserver reliability was assessed. The population-inclusive nonmetric and metric models produced cross-validated classification accuracies of 81.0–87.0% and 86.7–87.0%, respectively, which did not differ significantly from the accuracy of most population-specific models. Moreover, combined nonmetric and metric models increased accuracy to 88.8–91.6%. This study indicates that population-inclusive assigned-sex estimation models can be used instead of population-specific models in cases where ancestry is intentionally not estimated, given current concerns with ancestry estimation.
... Besides, the overall incidence of genitally ambiguous patients at birth remains undefined. Nevertheless, it has been reported that the incidence of DSD could span between 0.33 and 1.7% of all congenital reproductive organ abnormalities (Blackless et al., 2000;Nordenvall et al., 2014). 46,XY DSD encompass a wide category of phenotypes such as defective formation of gonads or gonadal dysgenesis, defects in androgen synthesis or action, while some may have normal testes with 5α reductase deficiency. ...
Full-text available
Background: 46,XY disorders/differences of sex development (46,XY DSD) are congenital conditions that result from abnormal gonadal development (gonadal dysgenesis) or abnormalities in androgen synthesis or action. During early embryonic development, several genes are involved in regulating the initiation and maintenance of testicular or ovarian-specific pathways. Recent reports have shown that MAP3K1 genes mediate the development of the 46,XY DSD, which present as complete or partial gonadal dysgenesis. Previous functional studies have demonstrated that some MAP3K1 variants result in the gain of protein function. However, data on possible mechanisms of MAP3K1 genes in modulating protein functions remain scant. Methods: This study identified a Han Chinese family with the 46,XY DSD. To assess the history and clinical manifestations for the 46,XY DSD patients, the physical, operational, ultra-sonographical, pathological, and other examinations were performed for family members. Variant analysis was conducted using both trio whole-exome sequencing (trio WES) and Sanger sequencing. On the other hand, we generated transiently transfected testicular teratoma cells (NT2/D1) and ovary-derived granular cells (KGN), with mutant or wild-type MAP3K1 gene. We then performed functional assays such as determination of steady-state levels of gender related factors, protein interaction and luciferase assay system. Results: Two affected siblings were diagnosed with 46,XY DSD. Our analysis showed a missense c.556A > G/p.R186G variant in the MAP3K1 gene. Functional assays demonstrated that the MAP3K1R186G variant was associated with significantly decreased affinity to ubiquitin (Ub; 43-49%) and increased affinity to RhoA, which was 3.19 ± 0.18 fold, compared to MAP3K1. The MAP3K1R186G led to hyperphosphorylation of p38 and GSK3β, and promoted hyperactivation of the Wnt4/β-catenin signaling. In addition, there was increased recruitment of β-catenin into the nucleus, which enhanced the expression of pro-ovarian transcription factor FOXL2 gene, thus contributing to the 46,XY DSD. Conclusion: Our study identified a missense MAP3K1 variant associated with 46,XY DSD. We demonstrated that MAP3K1R186G variant enhances binding to the RhoA and improves its own stability, resulting in the activation of the Wnt4/β-catenin/FOXL2 pathway. Taken together, these findings provide novel insights into the molecular mechanisms of 46,XY DSD and promotes better clinical evaluation.
... A intersexualidade compõe uma série de condições congênitas que desenvolve o corpo biológico com diferenças tanto sutis quanto significativas frente ao que acreditamos ser a "normalidade" para o corpo humano baseado no dimorfismo sexual (Blackless et al, 2000). Dito de outra maneira, essas diferenças do desenvolvimento do sexo (Lee et al, 2016) alteram a maneira usual do corpo biológico se diferenciar nos extremos da masculinidade ou da feminilidade. ...
Full-text available
Olympic Virtual Series (OVS), organized by the International Olympic Committee (IOC), has paved the way for eSports to become mainstream and represents the first steps taken by the IOC to enter the metaverse. This chapter is a case study on one of the OVS disciplines - cycling event - which utilized Zwift, an online multiplayer cycling training program. It also aims to explore the elements which will enable the IOC to integrate Olympic values and promote education and peace.
... Intersex people "are born with physical sex characteristics that don't fit medical and social norms for female or male bodies" (Intersex Human Rights Australia, 2013). Intersex includes more than 40 variations, can apply to one in 60 individuals (1.7%) and, be as frequent as someone being born with red hair (Blackless et al., 2000;Hiort, 2013;Intersex Human Rights Australia, 2014. In 2015 the Office of the UN High Commissioner for Human Rights published a factsheet on intersex which took a step away from defining intersex based on the medical model and rather based their description on human rights law: ...
Although pre-service Health and Physical Education (HPE) teachers may be acquainted with media headlines categorizing intersex bodies as “deviant,” “non-biological,” “different,” and/or “non-natural” in their reporting on eligibility testing in women's elite sports, few appear to be familiar with what intersex includes and what these tests were designed to reveal. Drawing on Evan and Rich's advocacy to critically analyse body-policies with strong normative body-pedagogies, this chapter unpacks how athletes marked by this category cannot be understood as separate from the corporeal instructions and ‘authorities' that mark and regulate their bodily representation. The chapter inspires and encourages HPE teachers to take the ‘risk' of engaging students in disruptive practices which explore the inscription of power onto particular bodies and abilities in sports and how they as both pedagogues and members of society are all ethically implicated in these relations of power.
This article addresses issues related to clinical and research approaches to oncofertility for adolescent and young adult (AYA) sexual and gender minority (SGM) cancer patients. Limited attention has been dedicated to understanding the extent to which oncofertility services are appropriately and equitably delivered to AYAs with diverse orientations toward sexual orientation, gender identity, and future family. Unresolved challenges to conducting research with this vulnerable population perpetuate a lack of adequate knowledge about SGM AYA oncofertility needs. Therefore, the purpose of this paper is to inform considerations of sex, gender identity, and sexual orientation for investigations that include SGM AYAs. In order to improve the knowledge base and clinical services for this population, we discuss (1) challenges to sampling this population; (2) categorization and survey logic (e.g., skip patterns) in light of fluid sexual orientation and gender identities; and (3) clinical implications of accurately assessing sex and gender for oncofertility research and practice. We also recommend strategies for producing inclusive and accurate assessments of sexual and gender identity categories in both research and clinical encounters with SGM AYAs. Incorporating “queer insights” into empirical research – that is, positioning queer theory at the center of oncofertility study design – is suggested as a future direction for oncofertility research and practice.
Full-text available
Simple reaction time (RT) can vary by sex, with males generally displaying faster RTs than females. Although several explanations have been offered, the possibility that response preparation differences may underlie the effect of sex on simple RT has not yet been explored. A startling acoustic stimulus (SAS) can involuntarily trigger a prepared motor response (i.e., StartReact effect), and as such, RT latencies on SAS trials and the proportion of these trials demonstrating startle-reflex EMG in the sternocleidomastoid (SCM) muscle are used as indirect measures of response preparation. The present study employed a retrospective analysis of composite individual participant data (IPD) from 25 datasets published between 2006 and 2019 to examine sex differences in response preparation. Linear mixed effects models assessed the effect of sex on control and SAS RT as well as the proportion of SAS trials with SCM activation while controlling for study design. Results indicated significantly longer control RT in female participants as compared to males (p=.017); however, there were no significant sex differences in SAS RT (p=.441) or the proportion of trials with startle reflex activity (p=.242). These results suggest that sex differences in simple RT are not explained by variations in levels of response preparation but instead may be the result of differences in perceptual processing and/or response initiation processes.
Full-text available
Sustentada por cerca de oitocentas referências científicas, sobretudo nos domínios da biologia, psicologia, psiquiatria e sociologia, esta obra biblioterápica salienta informações surpreendentes sobre o primeiro estágio da existência humana: in utero. É direcionada à população em geral, visando ampliar a sensibilização sobre a vida psíquica intrauterina, bem como aos profissionais de saúde, sugerindo-lhes a inclusão da Projeção Idealizada de Sexo (PIS) nos seus racionais teóricos, para práticas mais incisivas e efetivas. Fruto de cerca de vinte anos de trabalho, nesta obra os autores dissertam sobre a preferência parental pelo sexo dos filhos, ilustrando cinquenta casos clínicos trabalhados com Constelações Familiares (CF) como psicoterapia clássica. Dessa prática fenomenológica sistémica sobressaem múltiplas reflexões, como as sobre o patriarcado, o aborto sexo-seletivo, o feticídio feminino, a feminigligência, o feminicídio, o efeito fraterno na ordem do nascimento, a não-heterossexualidade e o incesto intrafamiliar. São também aqui facultadas informações sobre temas mais raros na literatura sobre CF, tais como a atitude fenomenológica, os esquemas sobre o «estar com o outro», os tipos de vinculação, as criptas psíquicas, os fantasmas sistémicos, as lealdades invisíveis e as heurísticas cognitivas. Os autores propõem ainda a adição de vários novos conceitos à literatura científica sobre psicoterapia, como o de frases homeostaticamente orientadas, protoesquema psíquico, falha arcaica, vinculação fictiva e o tema central desta obra, a PIS.
Prenatal diagnosis offers the possibility of ascertaining distinct genetic defects through the analysis of fetal cells obtained by amniocentesis. The amniotic fluid is withdrawn in the 16th or 17th gestational week through a transabdominal tap. The fetal cells in the sample are cultivated over 2 weeks and chromosomal preparations (or metabolic tests) are performed using standard methods.
A national register of congenital malformations covering about 80,000 annual births is described. The registration is intended to serve as an early warning system, should a new teratogen become widely spread in the environment. Such an instrument is very much needed, since existing methods for evaluation of teratogenic effects of exogenous factors–-especially drugs and other chemical substances–give no reliable protection to the human embryo. The essential of the registration procedure is that malformations observed during the newborn period are reported monthly to a malformation register by a verbal diagnosis or description–not by code numbers. The frequency of different malformations is thus kept under continuous control. The method was tested with available Swedish data from the thalidomide period. The results suggest that, had the register been at work at that time, it should have identified an epidemic some 5 months after the appearance of the first thalidomide embryopathies. A special effort has been made to analyze infants with multiple malformations. In only a minority of such cases can the child have been affected by two or more unrelated teratogens.
We reviewed 283 cases of human true hermaphroditism published from 1980 to 1992. Of the 96 cases described in Africa 96.9% showed a 46,XX karyotype. In Europe 40.5% of 74 cases and 21.0% of the patients in North America had chromosomal mosaicism. The 46,XY karyotype is extremely rare (7%) and equally distributed through Asia, Europe and North America. Of 283 cases 87 were of black or black mixed origin with a 46,XX chromosomal constellation. The most common gonad in patients with true hermaphroditism, an ovotestis, was found in 44.4% of 568 gonads. Gonads with testicular tissue were more frequent on the right side of the body, while pure ovarian tissue was more common on the left. Histologically the testicular tissue was described to be immature and only twice was spermatogenesis reported while the ovarian portion often appeared normal. This coincides with 21 pregnancies reported in ten true hermaphrodites while only one true hermaphrodite apparently has fathered a child. Of the patients 4.6% were reported to have gonadal tumours. Position and type of the genital ducts, frequency of clinical findings such as genital abnormalities and gynaecomastia, correlations between assigned sex and karyotype as well as the age at diagnosis are reported.